Sign in:
Email
 Password  save:
  
 Company Reports 
 

   
My Recent Searches
  Help
 
   
 
 
   Get Roster for :  
Lenz Therapeutics (LENZ)  
$31.38 1.32 (4.04%) as of 4:30 Thu 10/23


Download
   
  Company Roster

Total Insiders  : 18  
Total Direct Shares :
21,542,886
Total Indirect Shares :
18,357,207
 
% Held by Insiders:
84.37%
 
9 other people own 
 $34,319,992 Versant Ventures Vii Gp-G...
 $32,967,797 Lehrer-Graiwer Joshua
 $36,453,205 Porteus Matthew
 $110,725,240 Versant Vantage Ii Gp-Gp,...
 $461,549,529  
 
Filer's Name Relation Direct Date   Direct Shares Indirect Date Indirect Shares
   Versant Ventures Vii Gp-Gp, Llc 2025-09-30 1,050,599 2025-09-30 1,606,289
   Olsson Shawn Chief Commercial Officer 2025-04-09 4,733 2024-12-16 0
   Schimmelpennink Evert B. President, CEO and Secretary, Director 2025-03-07 49,200 2024-07-22 0
   Chevallard Daniel R. Chief Financial Officer 2024-05-14 3,188 2024-05-14 0
   Mccollum James W Director 2024-05-13 95,034 2024-05-13 525,565
   Odrich Marc Chief Medical Officer 2024-03-21 99,599 2024-03-21 0
   Shah Rajeev M. Director, 10% Owner 2024-03-21 0 2024-03-21 694,755
   Gutry Phil CHIEF BUSINESS OFFICER 2022-04-11 299,941 0
   Karsen Perry A Director 2021-06-29 164,034 0
   Shah Smital Director 2021-06-29 0 2021-06-29 5,882
   Jimenez Joseph Director 2021-06-29 161,941 0
   Akkaraju Srinivas 10% Owner 2021-06-29 0 2022-04-12 8,497,067
   Versant Vantage Ii Gp-Gp, Llc 10% Owner 2021-06-29 14,708,398 2021-06-29 1,707,719
   Lehrer-Graiwer Joshua PRESIDENT AND CEO, Director 2021-06-29 1,161,670 0
   Stultz Katherine V CHIEF OPERATING OFFICER 2021-06-29 216,020 0
   Porteus Matthew Director 2021-06-24 3,528,529 0
   Jerel Davis Director, 10% Owner 0 2021-06-29 1,707,719
   Chimera Investment Llc 10% Owner 0 2024-03-21 3,612,211
18 Records found